Percutaneous management of failed bioprosthetic pulmonary valves in patients with congenital heart defects

Aims: We reviewed our center experience in the field of transcatheter pulmonary valve-in-valve implantation (TPViV), that is emerging as a treatment option for patients with pulmonary bioprosthetic valve (BPV) dysfunction. Methods: Between April 2008 and September 2015, a total of six patients with congenital heart disease (four men) underwent TPViV due to stenosis of preexisting BPV. Four patients received a Melody Medtronic Transcatheter Pulmonary Valve and two an Edward Sapien Valve. Results: No procedural-related complications occurred. After valve implantation, right ventricular systolic pressure (RVSP, 80.5 ± 25.3–41.2 ± 8.35 mmHg, P 
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Valve disease Source Type: research